OCUP
Income statement / Annual
Last year (2023), Ocuphire Pharma, Inc.'s total revenue was $19.05 M,
a decrease of 52.20% from the previous year.
In 2023, Ocuphire Pharma, Inc.'s net income was -$9.99 M.
See Ocuphire Pharma, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$19.05 M
|
$39.85 M
|
$589,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$6,000.00 |
$4,000.00 |
$4,000.00 |
$8,000.00 |
$3,000.00 |
$48,211.00 |
$42,358.00 |
$32,916.00 |
$27,498.00 |
$0.00 |
| Gross Profit |
$19.04 M |
$39.85 M |
$585,000.00 |
-$8,000.00 |
-$3,000.00 |
-$48,211.00 |
-$42,358.00 |
-$32,916.00 |
-$27,498.00 |
$0.00 |
| Gross Profit Ratio |
1 |
1 |
0.99 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$17.65 M
|
$14.36 M
|
$15.17 M
|
$6.65 M
|
$2.37 M
|
$13.11 M
|
$10.72 M
|
$10.09 M
|
$12.15 M
|
$7.02 M
|
| General & Administrative
Expenses |
$11.96 M
|
$7.27 M
|
$8.12 M
|
$2.82 M
|
$1.82 M
|
$743,279.00
|
$6.64 M
|
$6.32 M
|
$6.12 M
|
$6.25 M
|
| Selling & Marketing
Expenses |
-$6,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$6.64 M
|
-$42,358.00
|
-$32,916.00
|
-$27,498.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$11.95 M
|
$7.27 M
|
$8.12 M
|
$2.82 M
|
$1.82 M
|
$7.38 M
|
$6.60 M
|
$6.29 M
|
$6.09 M
|
$6.25 M
|
| Other Expenses |
$1.84 M |
-$14,000.00 |
-$157,000.00 |
$9,000.00 |
-$68,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$29.61 M |
$21.62 M |
$23.29 M |
$9.47 M |
$4.19 M |
$20.49 M |
$17.31 M |
$16.38 M |
$18.24 M |
$13.27 M |
| Cost And Expenses |
$29.61 M |
$21.62 M |
$23.29 M |
$9.47 M |
$4.19 M |
$20.54 M |
$17.35 M |
$16.41 M |
$18.26 M |
$13.27 M |
| Interest Income |
$0.00 |
$150,000.00 |
$2,000.00 |
$6.85 M |
$313,700.00 |
$254,344.00 |
$207,003.00 |
$118,565.00 |
$103,269.00 |
$133,907.00 |
| Interest Expense |
$0.00 |
$9,000.00 |
$2,000.00 |
$6.85 M |
$1.41 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$6,000.00
|
$4,000.00
|
$4,000.00
|
$8,000.00
|
$3,000.00
|
$48,211.00
|
$42,358.00
|
$32,916.00
|
$27,498.00
|
$0.00
|
| EBITDA |
-$9.97 M
|
$18.23 M
|
-$56.69 M
|
-$19.97 M
|
-$4.19 M
|
-$14.32 M
|
-$25.25 M
|
-$8.96 M
|
-$14.36 M
|
-$13.27 M
|
| EBITDA Ratio |
-0.55 |
0.46 |
-38.81 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
-0.55
|
0.46
|
-38.55
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$589,000.00
|
-$23,000.00
|
-$33.99 M
|
-$4.65 M
|
-$1.98 M
|
$6.17 M
|
-$7.94 M
|
$7.11 M
|
$3.88 M
|
-$5.25 M
|
| Income Before Tax |
-$9.97 M |
$18.20 M |
-$56.69 M |
-$24.62 M |
-$6.17 M |
-$14.37 M |
-$25.29 M |
-$9.31 M |
-$14.38 M |
-$18.52 M |
| Income Before Tax Ratio
|
-0.52
|
0.46
|
-96.25
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$12,000.00 |
$315,000.00 |
-$159,000.00 |
$6.86 M |
$1.34 M |
-$161,141.00 |
$2.00 |
$5.00 |
$2.00 |
$0.00 |
| Net Income |
-$9.99 M |
$17.89 M |
-$56.53 M |
-$31.48 M |
-$7.51 M |
-$14.37 M |
-$25.29 M |
-$9.31 M |
-$14.38 M |
-$18.52 M |
| Net Income Ratio |
-0.52 |
0.45 |
-95.98 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| EPS |
-0.46 |
0.9 |
-3.81 |
-6.75 |
-10.56 |
-20.95 |
-44.33 |
-20.55 |
-37.86 |
-0.11 |
| EPS Diluted |
-0.46 |
0.87 |
-3.81 |
-6.75 |
-10.56 |
-20.95 |
-44.33 |
-20.55 |
-37.86 |
-0.11 |
| Weighted Average Shares
Out |
$21.59 M
|
$19.93 M
|
$14.85 M
|
$4.66 M
|
$711,208.00
|
$685,737.00
|
$570,635.00
|
$453,015.00
|
$379,975.00
|
$176.11 M
|
| Weighted Average Shares
Out Diluted |
$21.59 M
|
$20.60 M
|
$14.85 M
|
$4.66 M
|
$711,208.00
|
$685,737.00
|
$570,635.00
|
$453,015.00
|
$379,975.00
|
$176.11 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
